Table 1.
Patient characteristics
| n (%) | |
|---|---|
| Patient data | |
| Age (years; range) | 66 (47–84) |
| Total number | 61 (100%) |
| Benign prostatic hyperplasia (BPH) | 15 (24.6%) |
| Low-risk PC (D’Amico) | 16 (26.2%) |
| Intermediate PC (D’Amico) | 16 (26.2%) |
| High-risk PC (D’Amico) | 14 (23.0%) |
| PSA | |
| < 4 ng/ml | 2 (3.3%) |
| 4-10 ng/ml | 36 (59.0%) |
| 10-20 ng/ml | 12 (19.7%) |
| > 20 ng/ml | 5 (8.2%) |
| n/a | 6 (9.8%) |
| ISUP (Gleason-Score) | |
| 1 (6) | 17 (27.9%) |
| 2 (7a) | 14 (23.0%) |
| 3 (7b) | 1 (1.6%) |
| 4 (8) | 3 (4.9%) |
| 5 (9–10) | 11 (18.0%) |
| No cancer | 15 (24.6%) |
| T-stage | |
| pT2a | 7 (11.5%) |
| pT2b | 1 (1.6%) |
| pT2c | 28 (45.9%) |
| pT3/4 | 10 (16.4%) |
| No cancer | 15 (24.6%) |